BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 2001
View Archived Issues
Licensing opportunity from NIH: plasmid for production of more soluble form of HIV integrase protein
Read More
FDA approves new formulation of Reminyl
Read More
FluMist review by advisory committee scheduled for late July
Read More
Favorable delivery characteristics, therapeutic effects reported in humans for inhaled insulin
Read More
Pharmacokinetics of AERx iDMS compared in smokers and nonsmokers
Read More
Novel insulin formulations from Coremed highlighted at ENDO 2001
Read More
Xenical to be used in NIH-funded study on weight loss and diabetes
Read More
Pharmexa in-licenses PADRE technology from Epimmune
Read More
Immunomedics and IBC report on bispecific antibody studies
Read More
MitoKor acquires Apollo BioPharmaceutics
Read More
Osteoblast-stimulating activity reported for carnitine derivatives
Read More
Milkhaus begins clinical testing of ML-04 for chronic prostatitis
Read More
Preclinical results obtained by VaxGen suggest feasibility of broadly protective HIV vaccine
Read More
AZ-242, a novel PPARalpha/PPARgamma activator for insulin resistance syndrome, type 2 diabetes
Read More
Theratechnologies begins second phase II trial in sleep disorders; phase IIa results promising
Read More
Patient enrollment completed in phase II trial of Axonyx's phenserine
Read More
Complementary antihypertensive effect seen for farglitazar in rats and humans
Read More
E.C. approves Actiq via mutual recognition procedure
Read More
Health Canada grants approval for Crohn's disease treatment
Read More
ADA news: SGLT inhibitor RWJ-394718 has favorable effects in rodent models of type 2 diabetes
Read More
Lilly Icos seeks FDA approval of Cialis for erectile dysfunction
Read More
New data for Gleevec show increase in CML response rates over time
Read More
Combination therapies for certain malignancies discussed by Idec
Read More
Antiviral combination therapy of HBV reported by Glaxo
Read More
Acylsulfonamides as selective chymase inhibitors
Read More
Agents for H. pylori infections designed by AstraZeneca to have improved stability
Read More
Biogen presents new series with particular utility in CHF, renal dysfunction
Read More